Dr Mark Ratnarajah, practising NHS paediatrician and UK managing director for C2-Ai considers the role of technology in providing a new understanding of patient risk, and what this means for services as the NHS turns 75.
Dr Mark Ratnarajah, practising NHS paediatrician and UK managing director for C2-Ai considers the role of technology in providing a new understanding of patient risk, and what this means for services as the NHS turns 75.